Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
The authors discuss how to develop a cost-effective thermally protective packaging system.
Detecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
This study outlines methods for an alternative protein-polishing process for challenging proteins.
This study outlines methods for an alternative protein-polishing process for challenging proteins.
This study outlines methods for an alternative protein-polishing process for challenging proteins.
This study outlines methods for an alternative protein-polishing process for challenging proteins.
This study outlines methods for an alternative protein-polishing process for challenging proteins.
. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
This report explores rapid vaccine development during the pandemic and how process changes with the help of advanced manufacturing could aid the development of medicines.
The use of external retainers to enhance the seal between connectors and tubing is an essential component in single-use manufacturing systems.
Investing in a single source enterprise-wide LMS to fuel risk management and mitigation offers multi-dimensional return on investment.
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.
A new facility type integrates next-generation mobile cleanroom systems.
Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.